Teva Pharmaceutical Industries Limited · TASE:TEVA
Teva Pharmaceutical Industries — Fact Sheet (February 2004)
2 slides from Teva Pharmaceutical Industries's fact sheet, February 2004
Slide 1: Fact Sheet: Company Overview
FACT SHEET ramen Director, Investor Relations Teva Pharmaceutical Industries Ltd. February 2004 5 Basel St., P.0.Box 3190 * Petach Tikva 49131, Israel TEVA PHARMACEUTICAL INDUSTRIES LTD. Tel. ++972-3-926-7554 © Fax. ++972-3.926-7519 E-mail: [email protected] » website: www.tevapharm.com A Company Ove
Slide 2: Recent Events
Recent Events Feb. 17, 2004 - Teva reported its fourth quarter and 2003 annual financial results. Q4 sales amounted to $942 million (up 22%). Net income and EPS reached $186 million (up 36%) and $0.62 (up 24%), respectively. Jan. 30, 2004 - Teva announced that the U.S. Court of Appeals vacated a 200
Teva Pharmaceutical Industries — Fact Sheet (February 2004) on 6ix